Enanta Pharmaceuticals, Inc.

8-K Entered a material agreement Jul 2, 2026 8-K Other events Jun 23, 2026 8-K Regulation FD disclosure Jun 18, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Other events Mar 26, 2026 8-K Director or officer change; Shareholder vote results Mar 12, 2026 10-Q Quarter ended 2025-12-31 Feb 11, 2026 8-K Results of operations (earnings release) Feb 9, 2026 10-K Fiscal year ended 2025-09-30 Nov 19, 2025 8-K Results of operations (earnings release) Nov 17, 2025 8-K Other events Oct 1, 2025 8-K Regulation FD disclosure Sep 29, 2025 8-K Regulation FD disclosure; Other events Sep 29, 2025 8-K Director or officer change Aug 27, 2025 8-K Regulation FD disclosure; Other events Aug 20, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 11, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 12, 2025 8-K Director or officer change; Shareholder vote results Mar 17, 2025 10-Q Quarter ended 2024-12-31 Feb 12, 2025 8-K Results of operations (earnings release) Feb 10, 2025 8-K Regulation FD disclosure; Other events Dec 9, 2024 10-K Fiscal year ended 2024-09-30 Nov 27, 2024 8-K Results of operations (earnings release) Nov 25, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 5, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 6, 2024 8-K Director or officer change; Shareholder vote results Mar 12, 2024 10-Q Quarter ended 2023-12-31 Feb 8, 2024 8-K Results of operations (earnings release) Feb 7, 2024 8-K Director or officer change Dec 26, 2023 10-K Fiscal year ended 2023-09-30 Nov 22, 2023 8-K Results of operations (earnings release) Nov 20, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023 8-K Results of operations (earnings release) Aug 7, 2023 8-K Regulation FD disclosure Jun 7, 2023 10-Q Quarter ended 2023-03-31 May 9, 2023